Myriad Genetics Logo

Myriad Genetics

🇺🇸
MYGN
US62855J1043

Myriad Genetics is a leader in precision medicine, developing and marketing advanced genetic tests. These tests aid in the diagnosis, prognosis, and therapeutic decision-making for cancer and hereditary diseases. The company enhances patient care through innovative diagnostics, empowering healthcare providers with critical genetic insights for better outcomes.

Next Quarterly Earnings

Monday, November 9, 2026
CW 46
After-Hours
In 74 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Quiet period starts on October 12, 2026

Stock Price

Frequently asked questions

When will Myriad Genetics report its next quarterly earnings?

Myriad Genetics is scheduled to report its next quarterly earnings on 11/09/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did Myriad Genetics last report quarterly earnings?

Myriad Genetics last reported quarterly earnings on 7/30/2026 (Q2 2026). Earnings per share (EPS) came in at -0.25 USD.

How does Myriad Genetics stock react to earnings?

Across its last 3 earnings reports, Myriad Genetics stock moved by ±13.5% on average the following day. The largest reaction was -21% on 11/03/2025; 1 of 3 reactions were positive.

How often has Myriad Genetics beaten expectations?

Myriad Genetics has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).

How do I add the Myriad Genetics earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$0.19
Actual:
Q2 2026
Missed
Estimate:-$0.06
Actual:-$0.25
Difference:-$0.19
Q1 2026
Missed
Estimate:-$0.07
Actual:-$0.09
Difference:-$0.02
Price reaction (1 day):-18.3 %
Price reaction (7 days):-19.1 %
Q4 2025
Beat
Estimate:-$0.02
Actual:$0.04
Difference:+$0.06
Price reaction (1 day):+1.1 %
Price reaction (7 days):+14.4 %
Q3 2025
Beat
Estimate:-$0.01
Actual:$0.00
Difference:+$0.01
Price reaction (1 day):-21.0 %
Price reaction (7 days):-20.8 %
Q1 2025
Beat
Estimate:-$0.01
Actual:$0.05
Difference:+$0.06

Earnings statistics

Stock reaction to earnings

±13.5%
Avg. next-day move
-21%
Largest move (11/03/2025)
33.3%
Share of positive reactions
±18.1%
Avg. move after 7 days

Basis: price reactions to the last 3 report dates (close to close).

Estimates vs. results

3/5
Quarters above estimates
60%
Beat rate
-4.9%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Myriad Genetics
Ticker Symbol
MYGN
ISIN
US62855J1043
Country
🇺🇸
USA
Sector